"Bucladesine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
| Descriptor ID |
D003994
|
| MeSH Number(s) |
D03.633.100.759.646.138.395.250 D13.695.462.200.250 D13.695.667.138.395.250 D13.695.827.068.395.250
|
| Concept/Terms |
Bucladesine- Bucladesine
- Dibutyryl Adenosine 3,5 Monophosphate
- Dibutyryl Adenosine-3',5'-Monophosphate
- Adenosine-3',5'-Monophosphate, Dibutyryl
- Dibutyryl Adenosine 3',5' Monophosphate
- DBcAMP
- N',O'-Dibutyryl-cAMP
- N',O' Dibutyryl cAMP
- N(6),0(2')-Dibutyryl Cyclic AMP
- (But)(2) cAMP
- Dibutyryl Cyclic AMP
- AMP, Dibutyryl Cyclic
- Cyclic AMP, Dibutyryl
|
Below are MeSH descriptors whose meaning is more general than "Bucladesine".
Below are MeSH descriptors whose meaning is more specific than "Bucladesine".
This graph shows the total number of publications written about "Bucladesine" by people in this website by year, and whether "Bucladesine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bucladesine" by people in Profiles.
-
Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. J Biol Chem. 1995 Aug 18; 270(33):19417-21.
-
Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells. Hepatology. 1994 Jun; 19(6):1445-52.
-
Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. J Biol Chem. 1992 Nov 25; 267(33):23459-62.
-
Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol. 1992 Nov 13; 223(1):39-48.
-
Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem. 1991 Jan 05; 266(1):484-9.
-
Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP. Eur J Pharmacol. 1990 Nov 27; 191(2):129-40.
-
Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro. J Cell Physiol. 1987 Jul; 132(1):161-7.
-
Mechanistic aspects of gastric (H+ + K+)-ATPase. Ann N Y Acad Sci. 1982; 402:146-63.
-
Biosynthesis of prostaglandin E by rat superior cervical ganglia. J Neurochem. 1978 Jul; 31(1):13-9.